[Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
D000328:Adult; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013919:Thromboangiitis Obliterans / Q000188:drug therapy; D014665:Vasodilator Agents / Q000627:therapeutic use; D014970:Xanthines / Q000627:therapeutic use*
D009539:Nicotinic Acids; D014665:Vasodilator Agents; D014970:Xanthines
Proprietà terapeutiche dello xantinol-nicotinato nel trattamento delle arteriopatie obliteranti.